Intralink-Spine LLC (ILS) is a company formed to develop, manufacture, market, and sell a tissue modifying reagent that can be injected into the intervertebral disc of the human spine to increase crosslinking in the native collagen matrix. This injected reagent significantly strengthens the disc tissue, increases durability and tear resistance, and increases spinal joint stability for treatment of the largest cause of lower back pain — Degenerative Disc Disease (DDD). This treatment is also effective in addressing the now widely recognized problem of Adjacent Segment Disease (ASD) which is an unfortunate consequence of many of the traditional and emerging surgical procedures currently being performed to treat DDD. Our chemically made stabilizing device, created directly in the spinal disc, will address the unfulfilled medical need for an effective non-surgical solution which does not simply treat the symptoms and pain associated with lower back pain but mechanically corrects the cause of DDD and ASD.

www.intralinkllc.com

< BACK